Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Vyvgart“
Suchtreffer
Begriffe & Kennungen
Vyvgart · 4.6 Fertility, pregnancy and lactation · 2
Eintrag öffnenVyvgart · 4.8 Undesirable effects · 1
Eintrag öffnenVyvgart · 4.8 Undesirable effects · 2
Eintrag öffnenVyvgart · 4.8 · 19 b From spontaneous post-marketing reporting. c Subcutaneous administration only. d (e.g. injection site ras
Eintrag öffnenVyvgart · 4.8 · 6 System organ class Adverse reaction Frequency category Gastrointestinal disorders Nausea a Common Musculoske
Eintrag öffnenVyvgart · 4.8 · Adverse reactions are listed in Table 1 by system organ class and preferred term. Frequency categories are def
Eintrag öffnenVyvgart · 4.8 · Adverse reactions described in this section were identified in clinical trials and from post-marketing reports
Eintrag öffnenVyvgart · 4.8 · All other adverse reactions were mild or moderate with the exception of one case of myalgia (Grade 3).
Eintrag öffnenVyvgart · 4.8 · All other adverse reactions were mild or moderate with the exception of one case of myalgia (Grade 3).
Eintrag öffnenVyvgart · 4.8 · Description of selected adverse reactions
Eintrag öffnenVyvgart · 4.8 · Description of selected adverse reactions
Eintrag öffnenVyvgart · 4.8 · In the gMG ARGX-113-1704 placebo-controlled study with efgartigimod alfa intravenous, the most frequently repo
Eintrag öffnenVyvgart · 4.8 · In the pooled dataset from two clinical studies in gMG with efgartigimod alfa subcutaneous (n = 168), all inje
Eintrag öffnenVyvgart · 4.8 · Infections
Eintrag öffnenVyvgart · 4.8 · Infections
Eintrag öffnenVyvgart · 4.8 · Injection site reactions
Eintrag öffnenVyvgart · 4.8 · Procedural headache
Eintrag öffnenVyvgart · 4.8 · Procedural headache
Eintrag öffnenVyvgart · 4.8 · Procedural headache was reported in 4.8% of the patients treated with efgartigimod alfa and 1.2% of patients t
Eintrag öffnenVyvgart · 4.8 · Procedural headache was reported in 4.8% of the patients treated with efgartigimod alfa intravenous and 1.2% o
Eintrag öffnen